These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7796256)

  • 1. Ironing out the angles in p53.
    Nat Struct Biol; 1995 Apr; 2(4):253-4. PubMed ID: 7796256
    [No Abstract]   [Full Text] [Related]  

  • 2. Interhelical angles in the solution structure of the oligomerization domain of p53: correction.
    Clore GM; Omichinski JG; Sakaguchi K; Zambrano N; Sakamoto H; Appella E; Gronenborn AM
    Science; 1995 Mar; 267(5203):1515-6. PubMed ID: 7878474
    [No Abstract]   [Full Text] [Related]  

  • 3. Refined solution structure of the oligomerization domain of the tumour suppressor p53.
    Clore GM; Ernst J; Clubb R; Omichinski JG; Kennedy WM; Sakaguchi K; Appella E; Gronenborn AM
    Nat Struct Biol; 1995 Apr; 2(4):321-33. PubMed ID: 7796267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms.
    Jeffrey PD; Gorina S; Pavletich NP
    Science; 1995 Mar; 267(5203):1498-502. PubMed ID: 7878469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Filling in the blanks in the p53 protein structure.
    Pennisi E
    Science; 1996 Nov; 274(5289):921-2. PubMed ID: 8966571
    [No Abstract]   [Full Text] [Related]  

  • 6. High-resolution structure of the oligomerization domain of p53 by multidimensional NMR.
    Clore GM; Omichinski JG; Sakaguchi K; Zambrano N; Sakamoto H; Appella E; Gronenborn AM
    Science; 1994 Jul; 265(5170):386-91. PubMed ID: 8023159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An acetyl-methyl switch drives a conformational change in p53.
    Tong Q; Mazur SJ; Rincon-Arano H; Rothbart SB; Kuznetsov DM; Cui G; Liu WH; Gete Y; Klein BJ; Jenkins L; Mer G; Kutateladze AG; Strahl BD; Groudine M; Appella E; Kutateladze TG
    Structure; 2015 Feb; 23(2):322-31. PubMed ID: 25651062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic case study on using NMR models for molecular replacement: p53 tetramerization domain revisited.
    Chen YW; Clore GM
    Acta Crystallogr D Biol Crystallogr; 2000 Dec; 56(Pt 12):1535-40. PubMed ID: 11092918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour-suppressor genes. X-rays strike p53 again.
    Vogelstein B; Kinzler KW
    Nature; 1994 Jul; 370(6486):174-5. PubMed ID: 8028656
    [No Abstract]   [Full Text] [Related]  

  • 10. [P53 at the atomic scale: the multiple faces of a crystal].
    Hainaut P
    Bull Cancer; 1997 Jul; 84(7):747-51. PubMed ID: 9339202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The oligomerization domain of p53: crystal structure of the trigonal form.
    Miller M; Lubkowski J; Rao JK; Danishefsky AT; Omichinski JG; Sakaguchi K; Sakamoto H; Appella E; Gronenborn AM; Clore GM
    FEBS Lett; 1996 Dec; 399(1-2):166-70. PubMed ID: 8980144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53: a glimpse at the puppet behind the shadow play.
    Friend S
    Science; 1994 Jul; 265(5170):334-5. PubMed ID: 8023155
    [No Abstract]   [Full Text] [Related]  

  • 13. Crystal structure of a p53 core tetramer bound to DNA.
    Malecka KA; Ho WC; Marmorstein R
    Oncogene; 2009 Jan; 28(3):325-33. PubMed ID: 18978813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvements and extensions in the conformational database potential for the refinement of NMR and X-ray structures of proteins and nucleic acids.
    Kuszewski J; Gronenborn AM; Clore GM
    J Magn Reson; 1997 Mar; 125(1):171-7. PubMed ID: 9245376
    [No Abstract]   [Full Text] [Related]  

  • 15. Crystallographic analysis of an 8-mer p53 peptide analogue complexed with MDM2.
    Sakurai K; Schubert C; Kahne D
    J Am Chem Soc; 2006 Aug; 128(34):11000-1. PubMed ID: 16925398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligomerization of p53 upon cooperative DNA binding: towards a structural understanding of p53 function.
    Chene P; Jahnke W
    Angew Chem Int Ed Engl; 2002 May; 41(10):1702-4. PubMed ID: 19750689
    [No Abstract]   [Full Text] [Related]  

  • 17. Fragmenting the S100B-p53 interaction: combined virtual/biophysical screening approaches to identify ligands.
    Agamennone M; Cesari L; Lalli D; Turlizzi E; Del Conte R; Turano P; Mangani S; Padova A
    ChemMedChem; 2010 Mar; 5(3):428-35. PubMed ID: 20077460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of the DNA-binding-induced loop L1 conformational switch in an engineered human p53 protein.
    Emamzadah S; Tropia L; Vincenti I; Falquet B; Halazonetis TD
    J Mol Biol; 2014 Feb; 426(4):936-44. PubMed ID: 24374182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solution conformation of an essential region of the p53 transactivation domain.
    Botuyan MV; Momand J; Chen Y
    Fold Des; 1997; 2(6):331-42. PubMed ID: 9427007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain.
    Kussie PH; Gorina S; Marechal V; Elenbaas B; Moreau J; Levine AJ; Pavletich NP
    Science; 1996 Nov; 274(5289):948-53. PubMed ID: 8875929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.